I am a healthcare professional

Notice


Welcome to MEDICALLY. This website is a non-promotional international resource intended to facilitate transparent scientific exchange regarding developments in medical research and disease management. It is intended for healthcare professionals outside the United Kingdom (UK) and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Roche and Genentech do not support, endorse or recommend the unapproved use of any compound or service in your jurisdiction, including those discussed on this website.


Please refer to local product information for any medicinal products mentioned. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same. Healthcare professionals outside the US are required to register and log-in to access the full range of content available on this website.


By clicking on one of the healthcare professional buttons below, you acknowledge you have read and understood this message and that you are requesting access to MEDICALLY. If you are not a healthcare professional, please use the other links below to access information relevant to you.


Cookies


We use cookies on this site to enable the site to function properly and to enhance your user experience. Cookies are files stored in your browser, which most websites use to personalize your web experience. Your information will only be used to provide information that is relevant to you. It will not be used for any other purpose. If you wish to restrict or block cookies, which are set on your device, then you can do this through your browser settings.


You can find out more about cookies by browsing our Privacy Policy.

 

For healthcare professionals in Another Country browse medically.roche.com.

Not a healthcare professional? For individuals outside the US, browse Roche's patient website or roche.com. For individuals in the US, browse gene.com.

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

CMSC 2026

-
Coming soon
07:00 PM
Duration 120mins Charlotte, NC
Efficacy and Safety of Fenebrutinib vs Ocrelizumab in Primary Progressive Multiple Sclerosis: Primary Results of the Phase III FENtrepid Study
Jacqueline A. Nicholas, Amit Bar-Or, Jiwon Oh, Gavin Giovannoni, Maria Pia Sormani, Martin S. Weber, Sharon Stoll, H-Christian von Büdingen, Jon Lopez, Louise Roberts, Miriam Triyatni, Qi Qi, John N. Ratchford, Julie Napieralski, Alexandra Goodyear, Stephen L. Hauser, Ludwig Kappos

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
08:20 PM
Duration 20mins Charlotte, USA
A Decade of Pregnancy Outcomes in Women with Multiple Sclerosis Receiving Ocrelizumab: Analysis of Over 5000 Pregnancies
Kristne Krysko, Ruth Dobson, Sandra Vukusic, Kerstin Hellwig, Celia Oreja-Guevara, Carlo Pietrasanta, T McElrath, Agne Kazlauskaite, Germano Ferreira, Daniela Alves, Yuliang He, Chien-Ju Lin, Noemi Pasquarelli, Riley Bove

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
09:00 PM
Duration 120mins Charlotte, USA
No Evidence of Disease Activity on Intravenous or Subcutaneous Ocrelizumab in Treatment-Naive Relapsing Multiple Sclerosis in the OPERA (10 Yrs) and OCARINA II (2 Yrs) Trials
Scott D. Newsome; João Cerqueira; Diego Centonze; Anthony Traboulsee; Licinio Craveiro; Hans-Martin Schenble; Dusanka Zecevic; Catarina Figueirido; Qing Wang; Caroline Giacobino; Krzysztof Selmaj; Bruce A. C. Cree

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 120mins Charlotte, USA
Understanding the Impact and Burden of Menopause on Multiple Sclerosis Through a Targeted Literature Review
Arliene Ravelo, Elmor Pineda, Ibraheem Abioye

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 120mins Charlotte, USA
Association Between Socioeconomic Characteristics and Treatment Outcomes With Ocrelizumab in the CHIMES Trial of Black and Hispanic People With Multiple Sclerosis
Angel Chinea, Annette Okai, Anthony Reder, Bhupendra Khatri, Corey McGraw, David Jones, Dilraj Singh Sokhi, Evanthia Bernitsas, Faria Amjad, Gregory Wu, Ibraheem Abioye, Jugena Ndrio, Lawrence Goldstick, Lilyana Amezcua, Mitzi Williams, Nancy Monson

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 120mins Charlotte, USA
Effectiveness and Safety of Ocrelizumab in Patients With Pediatric- Vs Young Adult–Onset Multiple Sclerosis: An MSBase Registry Matched Cohort Analysis
Helmut Butzkueven, Anda Gershon, Fabien Bakdache, Erwan Muros-Le Rouzic, Corinne Manlius, Tim Spelman, Mario Habek, William Brown, Raed Alroughani, Tomas Kalincik, Seyed M. Baghbanian, Guy Laureys, Allan G. Kermode, Jens Kuhle, Matteo Foschi, Jose E. Meca-Lallana, Radek Ampapa, Pierre Duquette, Yolanda Blanco, Abdorezza N. Moghadasi, Gregor Brecl Jakob, Murat Terzi, Bassem Yamout, Simón Cárdenas-Robledo and the MSBase Study Group

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 120mins Charlotte, USA
Real-World Impact of Discontinuing Ocrelizumab on Healthcare Resource Utilization and Cost Among Older Adult Patients With Multiple Sclerosis in the United States
Achal Patel, Danny Sheinson, Elmor Pineda, Ibraheem Abioye, Zhiyu Xia

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 120mins Charlotte, USA
Real-World Study of Ocrelizumab and Other Disease-Modifying Therapy Utilization and Disease Activity from Preconception through Postpartum in Women With MS
Arliene Ravelo, Danny Sheinson, Elmor Pineda, Erwan Muros, Maria Houtchens, Noemi Pasquarelli, Zhiyu Xia

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 120mins Charlotte, USA
Treatment Patterns of Ocrelizumab Subcutaneous: An Early Look Into Utilization in a Medicare Population With Multiple Sclerosis
Pineda, Elmor D.; Cellia, Johanna; Kardel, Peter;Sheetz, Caitlin; Abioye, Ibraheem

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
11:00 AM
Duration 20mins Room E216ABCD
Efficacy and Safety of Fenebrutinib vs Teriflunomide in Relapsing Multiple Sclerosis: Results of the FENhance 1 and 2 Studies
Jacqueline A. Nicholas, Jiwon Oh, Amit Bar-Or, Gavin Giovannoni, Maria Pia Sormani, Martin S. Weber, Sharon Stoll, H.-Christian von Büdingen, Marquita Decker-Palmer, Anastasia Loukitcheva, Miriam Triyatni, Nan Hu, Yoonha Choi, John N. Ratchford, Julie Napieralski, Alexandra Goodyear, Ludwig Kappos, Stephen L. Hauser

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar